gs-5885
Showing 1 - 5 of 5
Hepatitis C, Chronic Trial in Australia, Puerto Rico, United States (GS-5885, GS-9451, peginterferon alfa-2a)
Completed
- Hepatitis C, Chronic
- GS-5885
- +4 more
-
Tucson, Arizona
- +22 more
Jan 2, 2014
Hepatitis C, Chronic Trial in Puerto Rico, United States (GS-5885, Tegobuvir, GS-9451)
Completed
- Hepatitis C, Chronic
- GS-5885
- +3 more
-
Birmingham, Alabama
- +42 more
Nov 26, 2013
Hepatitis C, Chronic Trial in Germany, United States (GS-5885, GS-9451, tegobuvir)
Completed
- Hepatitis C, Chronic
- GS-5885
- +5 more
-
Tucson, Arizona
- +50 more
Nov 22, 2013
Chronic Hepatitis C Trial in Worldwide (GS-5885, GS-9451, RBV)
Terminated
- Chronic Hepatitis C
- GS-5885
- +3 more
-
Los Angeles, California
- +54 more
Jan 2, 2014
HCV Infection Trial in United States (GS-5885, Placebo)
Completed
- HCV Infection
- GS-5885
- Placebo
-
Anaheim, California
- +12 more
Jan 18, 2013